Elekta's Nomination Committee for the 2018 Annual General Meeting

STOCKHOLM, November 22, 2017 – In accordance with the resolution passed by Elekta's (EKTA-B.ST) Annual General Meeting on August 23, 2017, the Chairman of the Board has contacted the company's four largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself, each of whom expressed an interest in participating in the Nomination Committee, and appointed one member (see below) to form Elekta's Nomination Committee together with the Chairman of the Board. The procedure is described in detail in the notice of the 2017 Annual General Meeting.

Nomination Committee members:

  • Laurent Leksell, in his capacity as Chairman of the Board of Elekta and representing his own and related parties’ holdings
  • Åsa Nisell, appointed by Swedbank Robur funds
  • Per Colleen, appointed by the Fourth Swedish National Pension Fund
  • Magnus Henjeby, appointed by Nordea Investment funds
  • Tomas Flodén, appointed by AMF and AMF Funds

The Nomination Committee will appoint one of its members as Chairman.

The Nomination Committee is to present proposals for resolutions by the 2018 Annual General Meeting of Shareholders in relation to the following: Chairman of the Annual General Meeting of Shareholders, Chairman of the Board of Directors and other members of the Board of Directors, Fees to the Board of Directors broken down into amounts for the Chairman of the Board of Directors, other members of the Board of Directors and members of the Board of Directors’ committees, External auditor and fees to the auditor, and where deemed necessary, proposal to amend the procedure for the Nomination Committee.

Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail to valberedningen@elekta.com or by letter to:
Elekta AB, Nomination Committee
Box 7593
SE-103 93 Stockholm

# # #

About Elekta

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm www.elekta.com

Press Releases


PDF Version

For further information, please contact

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451,
E-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242,
E-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time